🇺🇸 TISSEEL Lyo in United States

35 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 23 April 2025 – 23 April 2026
• Total reports: 35

Most-reported reactions

1. Drug Ineffective — 6 reports (17.14%)
2. Pterygium — 5 reports (14.29%)
3. Post Procedural Oedema — 4 reports (11.43%)
4. Pseudomeningocele — 4 reports (11.43%)
5. Conjunctival Granuloma — 3 reports (8.57%)
6. Disease Recurrence — 3 reports (8.57%)
7. Drug Effect Decreased — 3 reports (8.57%)
8. Post Lumbar Puncture Syndrome — 3 reports (8.57%)
9. Cerebrospinal Fluid Leakage — 2 reports (5.71%)
10. Conjunctival Hyperaemia — 2 reports (5.71%)

Source database →

Frequently asked questions

Is TISSEEL Lyo approved in United States?

TISSEEL Lyo does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for TISSEEL Lyo in United States?

Baxter Healthcare Corporation is the originator. The local marketing authorisation holder may differ — check the official source linked above.